We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

ConvaTec Group Plc (CTEC) Ord GBP0.1

Sell:274.60p Buy:275.00p 0 Change: 9.40p (3.30%)
FTSE 100:0.48%
Market closed |  Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend today
Sell:274.60p
Buy:275.00p
Change: 9.40p (3.30%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend today
Sell:274.60p
Buy:275.00p
Change: 9.40p (3.30%)
Market closed |  Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend today
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Its Advanced Wound Care includes advanced solutions for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories and personalized services for individuals with a stoma. Its Continence and Critical Care includes products and services for people with urinary continence issues, and other devices for critical care. Its Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.

Contact details

Address:
7th Floor, 20 Eastbourne Terrace
LONDON
W2 6LG
United Kingdom
Telephone:
+ (0)
Website:
https://www.convatecgroup.com/

Important dates

Future events
Final dividend payment date 23 May 2024 23/05/24
Trading Announcement 16 May 2024 16/05/24
AGM 16 May 2024 16/05/24
Past events
Final ex-dividend date 25 April 2024 25/04/24
Annual report 15 April 2024 15/04/24
Final results 06 March 2024 06/03/24
Trading Announcement 14 November 2023 14/11/23
Interim dividend payment date 28 September 2023 28/09/23
Interim ex-dividend date 17 August 2023 17/08/23
Interim results 15 August 2023 15/08/23
Interim results 02 August 2023 02/08/23
Final dividend payment date 25 May 2023 25/05/23
Trading Announcement 18 May 2023 18/05/23
AGM 18 May 2023 18/05/23

General stock information

EPIC:
CTEC
ISIN:
GB00BD3VFW73
Market cap:
£5.65 billion
Shares in issue:
2.05 billion
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 100,FTSE 350,FTSE All Share

Key personnel

  • Karim Bitar
    Chief Executive Officer, Executive Director
  • Jonny Mason
    Chief Financial Officer, Executive Director
  • Anne Belcher
    President and Chief Operating Officer - Global Emerging Markets
  • Kjersti Grimsrud
    President and Chief Operating Officer - Infusion Care
  • Bruno Pinheiro
    President and Chief Operating Officer - Ostomy Care
  • Seth Segel
    President and Chief Operating Officer - Continence Care and Home Services Group
  • David Shepherda
    President and Chief Operating Officer - Advanced Wound Care
  • Natalia Kozmina
    Chief Human Resource Officer, Executive Vice President and ESG Stewardship
  • Divakar Ramakrishnan
    Executive Vice President, Chief Technology Officer and Head of Research and Development
  • Evelyn Douglas
    Executive Vice President, Chief of Corporate Strategy and Business Development, General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.